Proactive therapy of atopic dermatitis - An emerging concept

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 2, 2009, Pages 276-278

  Wollenberg, A ^a   Bieber, T ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; CALCINEURIN INHIBITOR; EMOLLIENT AGENT; FLUTICASONE; GLUCOCORTICOID; METHYLPREDNISOLONE ACEPONATE; PLACEBO; TACROLIMUS;

ATOPIC DERMATITIS; CLINICAL TRIAL; COST OF ILLNESS; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; EDITORIAL; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; LOW DRUG DOSE; PATHOPHYSIOLOGY; PHOTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

ANTI-ALLERGIC AGENTS; CLINICAL TRIALS AS TOPIC; DERMATITIS, ATOPIC; HUMANS; SKIN;

EID: 58649107102     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2008.01803.x     Document Type: Editorial

References (27)

1. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB Jr., Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005 22 : 192 199.
2. Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol 2006 154 : 719 725.
3. Darsow U, Lubbe J, Taieb A, Seidenari S, Wollenberg A, Calza A et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005 19 : 286 295.
4. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006 61 : 969 987.
5. Wollenberg A, Reitamo S, Girolomoni G, Lahfa M, Ruzicka T, Healy E et al. A novel approach to disease control with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a randomized, multicentre, comparative study. Allergy 2008 63 : 742 750.
6. Proksch E, Folster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006 43 : 159 169.
7. Ogawa H, Yoshiike T. Atopic dermatitis: studies of skin permeability and effectiveness of topical PUVA treatment. Pediatr Dermatol 1992 9 : 383 385.
8. Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985 65 : 102 105.
9. Holm EA, Wulf HC, Thomassen L, Jemec GB. Instrumental assessment of atopic eczema: validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema. J Am Acad Dermatol 2006 55 : 772 780.
10. Kerschenlohr K, Darsow U, Burgdorf WHC, Ring J, Wollenberg A. Lessons of atopy patch testing in atopic dermatitis. Curr Allergy Asthma Rep 2004 4 : 285 289.
11. Darsow U, Laifaoui J, Kerschenlohr K, Wollenberg A, Przybilla B, Wüthrich B et al. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 2004 59 : 1318 1325.
12. Habig J, Vocks E, Kautzky F, Ring J. Biophysical characteristics of healthy skin and nonlesional skin in atopic dermatitis: short-term effects of ultraviolet A and B irradiation. Skin Pharmacol Appl Skin Physiol 2000 13 : 174 181.
13. Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002 119 : 166 173.
14. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006 38 : 441 446.
15. Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006 118 : 214 219.
16. Braun-Falco O, Plewig G, Wolff H, Burgdorf W. Dermatology, 3rd edn. New York Heidelberg Berlin : Springer, 2000.
17. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007 120 : 150 155.
18. Mihm MC, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976 67 : 305 312.
19. Bieber T, Braun-Falco O. IgE-bearing Langerhans cells are not specific to atopic eczema but are found in inflammatory skin diseases. J Am Acad Dermatol 1991 24 : 658 659.
20. Bieber T, de la Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med 1992 175 : 1285 1290.
21. Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Födinger D et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via FcεRI. J Exp Med 1992 175 : 1353 1365.
22. Semper AE, Heron K, Woollard AC, Kochan JP, Friedmann PS, Church MK et al. Surface expression of Fc epsilon RI on Langerhans' cells of clinically uninvolved skin is associated with disease activity in atopic dermatitis, allergic asthma, and rhinitis. J Allergy Clin Immunol 2003 112 : 411 419.
23. Wollenberg A, Wen S, Bieber T. Phenotyping of epidermal dendritic cells - clinical applications of a flow cytometric micromethod. Cytometry 1999 37 : 147 155.
24. Hanifin J, Gupta AK, Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol 2002 147 : 528 537.
25. Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003 326 : 1367 1372.
26. Peserico A, Städtler G, Sebastian M, Suarez Fernandez R, Vick K, Bieber T. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 2008 158 : 801 807.
27. Bieber T. Atopic dermatitis. New Eng J Med 2008 358 : 1483 1494.